Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 40875 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–868] 

Importer of Controlled Substances 

Application: Cerilliant Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cerilliant Corporation has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 30, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 30, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on June 23, 2021, 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................... 1233 I 

Cathinone ................................................................................................................................................................ 1235 I 

Methcathinone ......................................................................................................................................................... 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) ........................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................... 1249 I 

Naphyrone ............................................................................................................................................................... 1258 I 

N-Ethylamphetamine ............................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine ...................................................................................................................................... 1480 I 

Fenethylline ............................................................................................................................................................. 1503 I 

Methaqualone .......................................................................................................................................................... 2565 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................... 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ 7008 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7012 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. 7019 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7023 I 

THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ......................................................... 7024 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ....... 7031 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... 7035 I 

APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) .................................................... 7048 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... 7081 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ........................................................... 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. 7203 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... 7225 I 

Alpha-ethyltryptamine .............................................................................................................................................. 7249 I 

Ibogaine ................................................................................................................................................................... 7260 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .................................. 7298 I 

Lysergic acid diethylamide ...................................................................................................................................... 7315 I 

2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ....................................................................................... 7348 I 

Marihuana ................................................................................................................................................................ 7360 I 

Parahexyl ................................................................................................................................................................. 7374 I 

Mescaline ................................................................................................................................................................ 7381 I 

2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) .................................................................................. 7385 I 

3,4,5-Trimethoxyamphetamine ................................................................................................................................ 7390 

4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................... 7395 I 

2,5-Dimethoxyamphetamine .................................................................................................................................... 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 7398 I 

3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 7404 I 


jbell on DSKJLSW7X2PROD with NOTICES
40876 Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 

Controlled substance Drug code Schedule 

3,4-Methylenedioxymethamphetamine .................................................................................................................... 7405 I 

4-Methoxyamphetamine .......................................................................................................................................... 7411 I 

5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................... 7431 I 

Alpha-methyltryptamine ........................................................................................................................................... 7432 I 

Bufotenine ............................................................................................................................................................... 7433 I 

Diethyltryptamine ..................................................................................................................................................... 7434 I 

Dimethyltryptamine .................................................................................................................................................. 7435 I 

Psilocybin ................................................................................................................................................................ 7437 I 

Psilocyn ................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................... 7439 I 

N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................ 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................ 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... 7470 I 

N-Benzylpiperazine ................................................................................................................................................. 7493 I 

4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ............................................................................................. 7498 I 

2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .......................................................................................... 7508 I 

2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................. 7509 I 

2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) .......................................................................................................... 7517 I 

2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................. 7518 I 

2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ........................................................................................... 7519 I 

2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ............................................................................................ 7521 I 

2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ..................................................................................... 7524 I 

2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ............................................................................ 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 7535 I 

25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................ 7536 I 

25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................ 7537 I 

25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................. 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. 7540 I 

Butylone ................................................................................................................................................................... 7541 I 

Pentylone ................................................................................................................................................................. 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................. 7546 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................... 7694 I 

Desomorphine ......................................................................................................................................................... 9055 I 

Etorphine (except HCl) ............................................................................................................................................ 9056 I 

Codeine methylbromide ........................................................................................................................................... 9070 I 

Heroin ...................................................................................................................................................................... 9200 I 

Morphine-N-oxide .................................................................................................................................................... 9307 I 

Normorphine ............................................................................................................................................................ 9313 I 

Pholcodine ............................................................................................................................................................... 9314 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................... 9547 I 

AH–7921 (3,4-dichloro-N-[(1- dimethylamino)cyclohexylmethyl]benzamide)) ........................................................ 9551 I 

Acetylmethadol ........................................................................................................................................................ 9601 I 

Allylprodine .............................................................................................................................................................. 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol .............................................................................................. 9603 I 

Alphameprodine ...................................................................................................................................................... 9604 I 

Alphamethadol ......................................................................................................................................................... 9605 I 

Betacetylmethadol ................................................................................................................................................... 9607 I 

Betameprodine ........................................................................................................................................................ 9608 I 

Betamethadol .......................................................................................................................................................... 9609 I 

Betaprodine ............................................................................................................................................................. 9611 I 

Dextromoramide ...................................................................................................................................................... 9613 I 

Dipipanone .............................................................................................................................................................. 9622 I 

Hydroxypethidine ..................................................................................................................................................... 9627 I 

Noracymethadol ...................................................................................................................................................... 9633 I 

Norlevorphanol ........................................................................................................................................................ 9634 I 

Normethadone ......................................................................................................................................................... 9635 I 

Racemoramide ........................................................................................................................................................ 9645 I 

Trimeperidine ........................................................................................................................................................... 9646 I 

1-Methyl-4-phenyl-4-propionoxypiperidine .............................................................................................................. 9661 I 

Tilidine ..................................................................................................................................................................... 9750 I 

Para-Fluorofentanyl ................................................................................................................................................. 9812 I 

3-Methylfentanyl ...................................................................................................................................................... 9813 I 

Alpha-methylfentanyl ............................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ..................................................................................................................................... 9815 I 

Beta-hydroxyfentanyl ............................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ......................................................................................................................................... 9832 I 

3-Methylthiofentanyl ................................................................................................................................................ 9833 I 

Thiofentanyl ............................................................................................................................................................. 9835 I 

Fentanyl related-substances as defined in 21 CFR 1308.11(h) ............................................................................. 9850 I 

Methamphetamine ................................................................................................................................................... 1105 II 

Methylphenidate ...................................................................................................................................................... 1724 II 

Amobarbital ............................................................................................................................................................. 2125 II 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 40877 

Controlled substance Drug code Schedule 

Pentobarbital ........................................................................................................................................................... 2270 II 

Secobarbital ............................................................................................................................................................. 2315 II 

Glutethimide ............................................................................................................................................................ 2550 II 

Nabilone .................................................................................................................................................................. 7379 II 

1-Phenylcyclohexylamine ........................................................................................................................................ 7460 II 

Phencyclidine .......................................................................................................................................................... 7471 II 

Phenylacetone ......................................................................................................................................................... 8501 II 

1-Piperidinocyclohexanecarbonitrile ........................................................................................................................ 8603 II 

Alphaprodine ........................................................................................................................................................... 9010 II 

Dihydrocodeine ........................................................................................................................................................ 9120 II 

Ecgonine .................................................................................................................................................................. 9180 II 

Ethylmorphine .......................................................................................................................................................... 9190 II 

Levomethorphan ...................................................................................................................................................... 9210 II 

Levorphanol ............................................................................................................................................................. 9220 II 

Meperidine ............................................................................................................................................................... 9230 II 

Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II 

Levo-alphacetylmethadol ......................................................................................................................................... 9648 II 

Noroxymorphone ..................................................................................................................................................... 9668 II 

Racemethorphan ..................................................................................................................................................... 9732 II 

Alfentanil .................................................................................................................................................................. 9737 II 

Remifentanil ............................................................................................................................................................. 9739 II 

Sufentanil ................................................................................................................................................................. 9740 II 

Carfentanil ............................................................................................................................................................... 9743 II 

Tapentadol ............................................................................................................................................................... 9780 II 

The company plans to import the 

listed controlled substances for the 

manufacturing of analytical reference 

standards and distribution to their 

research and forensic customers. 

Approval of permit application will 

occur only when the registrant’s activity 

is consistent with what is authorized 

under 21 U.S.C. 952(a)(2). Authorization 

will not extend to the import of Food 

and Drug Administration-approved or 

non-approved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–16136 Filed 7–28–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–871] 

Importer of Controlled Substances 

Application: Purisys, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Purisys, LLC. has applied to 

be registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplementary Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 30, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 30, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on June 29, 2021, Purisys, 

LLC., 1550 Olympic Drive, Athens, 

Georgia 3601–1602, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Opium, raw ..................... 9600 II 

Opium, powdered ........... 9639 II 

Opium, granulated .......... 9640 II 

The company plans to import Opium, 

raw (9600), Opium, powered (9639) and 

Opium, granulated (9640) to 

manufacture Active Pharmaceutical 

Ingredient (API) only for distribution to 

its customers. No other activity for these 

drug codes is authorized for this 

registration. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C. 952(a)(2). Authorization 

will not extend to the import of the 

Food and Drug Administrationapproved or non-approved finished 

dosage forms for commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–16142 Filed 7–28–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Request for Nominations for 

Membership on the Native American 

Employment and Training Council 

AGENCY: Employment and Training 

Administration, Labor. 

ACTION: Request for nominations. 

SUMMARY: The Department of Labor 

(DOL) invites interested parties to 

submit nominations for individuals to 

serve on the Native American 

Employment and Training Council 

(NAETC) and announces the procedures 

for those nominations. When submitting 

nomination materials, please indicate 

the Region or Discipline for which the 

nominee would like to be considered. 

Information regarding the NAETC can 


jbell on DSKJLSW7X2PROD with NOTICES

I I